Patent classifications
A23V2250/55
COMPOSITION COMPRISING CRICKET OR EXTRACT THEREOF FOR IMPROVING BOWEL MOVEMENT FUNCTION
The present invention relates to a composition comprising Cricket or an extract thereof for improving a bowel movement function or weight loss.
Probiotic Stabilization
An ingestible composition including a probiotic contained in a mixture of hydrolyzed mammalian protein, one or more carbohydrates and a compound binder useful for nutrition of infants and children.
Probiotic Stabilization
An ingestible composition including a probiotic contained in a mixture of hydrolyzed mammalian protein, one or more carbohydrates and a compound binder useful for nutrition of infants and children.
NOVEL CHEESE AND METHOD FOR PRODUCING THE SAME
The invention relates to a cheese includes angiogenin and/or angiogenin hydrolysate in an amount of 6.5 mg/100 g to 160 mg/100 g, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.02 to 1.6.
OPIOID PEPTIDE
The present invention relates to an opioid peptide represented by general formula
TyrProPhe-X1-TrpGlyGly-X2-ProPro, wherein: X1 is represented by Gly or Lys; X2 is represented by Ile or Val.
The invention also relates to pharmaceutical, nutritional and nutraceutical compositions comprising the peptide and to the use of the same for analgesic purposes, and/or for providing a feeling of satiety, and/or for lowering arterial blood pressure in a subject.
OPIOID PEPTIDE
The present invention relates to an opioid peptide represented by general formula
TyrProPhe-X1-TrpGlyGly-X2-ProPro, wherein: X1 is represented by Gly or Lys; X2 is represented by Ile or Val.
The invention also relates to pharmaceutical, nutritional and nutraceutical compositions comprising the peptide and to the use of the same for analgesic purposes, and/or for providing a feeling of satiety, and/or for lowering arterial blood pressure in a subject.
OPIOID PEPTIDE
The present invention relates to an opioid peptide represented by general formula TyrGlyGly-X1-X2-X3-X4, wherein: X1 is represented by Thr or Glu; X1 is represented by Gly or Thr or Ala; X3 is represented by Ala or Val or Gly or Glu; and X4 is represented by His or Gln or Thr or SEQ ID NO:1, or HisTyr or GlnTyr or ThrTyr.
The invention also relates to pharmaceutical and food compositions comprising the peptide and to the use of the same for analgesic purposes, and/or for providing a feeling of satiety to a subject.
OPIOID PEPTIDE
The present invention relates to an opioid peptide represented by general formula TyrGlyGly-X1-X2-X3-X4, wherein: X1 is represented by Thr or Glu; X1 is represented by Gly or Thr or Ala; X3 is represented by Ala or Val or Gly or Glu; and X4 is represented by His or Gln or Thr or SEQ ID NO:1, or HisTyr or GlnTyr or ThrTyr.
The invention also relates to pharmaceutical and food compositions comprising the peptide and to the use of the same for analgesic purposes, and/or for providing a feeling of satiety to a subject.
NOVEL POWDERED MILK PRODUCT AND METHOD FOR PRODUCING THE SAME
The invention relates to a powdered milk product includes angiogenin and/or angiogenin hydrolysate in an amount of 1.4 to 24 mg/15 g, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.03 to 1.3.
NOVEL POWDERED MILK PRODUCT AND METHOD FOR PRODUCING THE SAME
The invention relates to a powdered milk product includes angiogenin and/or angiogenin hydrolysate in an amount of 1.4 to 24 mg/15 g, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.03 to 1.3.